Quest Diagnostics Inc. (NYSE:DGX) Q3 2023 Results Conference Call October 24, 2023 8:30 AM ET Company Participants Shawn Bevec - VP, IR Jim Davis - Chairman, President & CEO Sam Samad - CFO Conference Call Participants Ann Hynes - Mizuho Securities David Westenberg - Piper Sandler Kieran Ryan - Deutsche Bank Elizabeth Anderson - Evercore Kevin Caliendo - UBS Jack Meehan - Nephron Research Patrick Donnelly - Citi Erin Wright - Morgan Stanley Brian Tanquilut - Jefferies Lisa Gill - JP Morgan Operator Welcome ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated 500 Plaza Drive Indicate by check mark whether the registrant has submi ...

Quest Diagnostics, Inc. (NYSE:DGX) Q2 2023 Earnings Conference Call July 26, 2023 8:30 AM ET Company Participants Shawn Bevec - VP, IR James Davis - Chairman, CEO & President Sam Samad - EVP & CFO Conference Call Participants Jack Meehan - Nephron Research Elizabeth Anderson - Evercore ISI A.J. Rice - Crédit Suisse Lisa Gill - JPMorgan Chase & Co. Eric Coldwell - Robert W. Baird & Co. Philip Chickering - Deutsche Bank Brian Tanquilut - Jefferies Kevin Caliendo - UBS Patrick Donnelly - Citigroup Operator Wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 500 Plaza Drive (State of Incorporation) (I.R.S. Employer Identification Number) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly perio ...

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Shawn Bevec - Vice President, Investor Relations Jim Davis - Chairman and Chief Executive Officer and President Sam Samad - Chief Financial Officer. Conference Call Participants Ann Hynes - Mizuho Securities Patrick Donnelly - Citigroup Brian Tanquilut - Jefferies Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Jack Meehan - Nephron Research Erin Wright - Morgan Stanley Kieran Rya ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 500 Plaza Drive (State of Incorporation) (I.R.S. Employ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number 001-12215 Quest Diagnostics Incorporated 500 Plaza Drive Secaucus, NJ 07094 (973) 520-2700 Delaware 16-1387862 ...

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2022 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice President, Chief Financial Officer Shawn Bevec - Vice President, Investor Relations Conference Call Participants Ann Hynes - Mizuho Securities Patrick Donnelly - Citi Jack Meehan - Nephron Research AJ Rice - Credit Suisse Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Kevin Caliendo - UBS Andrew Brac ...

Quest Diagnostics Incorporated (NYSE:DGX) Q3 2022 Earnings Conference Call October 20, 2022 8:30 AM ET Company Participants Shawn Bevec - VP of IR Steve Rusckowski - Chairman, President & Chief Executive Officer Jim Davis - CEO Sam Samad - CFO Conference Call Participants Ann Hynes - Mizuho Securities Kevin Caliendo - UBS Jack Meehan - Nephron Research Erin Wright - Morgan Stanley Brian Tanquilut - Jefferies A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Patrick Donnelly - Citi Operator Welcome t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12215 Quest Diagnostics Incorporated Delaware 16-1387862 (State of Incorporation) (I.R.S. Employer Identific ...